TABLE 7.
Top 10 most co-cited references related to GM in AS.
| Rank | Title | Citation | Centrality | Year | Source | References |
| 1 | Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. | 235 | 0.05 | 2013 | Nature Medicine | (5) |
| 2 | Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. | 199 | 0.01 | 2013 | New England Journal of Medicine | (37) |
| 3 | Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. | 161 | 0.02 | 2011 | Nature | (36) |
| 4 | Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. | 123 | 0.05 | 2016 | Cell | (81) |
| 5 | Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. | 119 | 0.02 | 2015 | Cell | (82) |
| 6 | Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. | 109 | 0.1 | 2013 | Cell Metabolism | (83) |
| 7 | Symptomatic atherosclerosis is associated with an altered gut metagenome. | 94 | 0.1 | 2012 | Nature Communications | (3) |
| 8 | The gut microbiome in atherosclerotic cardiovascular disease. | 80 | 0.04 | 2017 | Nature Communications | (4) |
| 9 | Transmission of atherosclerosis susceptibility with gut microbial transplantation. | 77 | 0.05 | 2015 | Journal of Biological Chemistry | (84) |
| 10 | Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. | 75 | 0.01 | 2016 | mBio | (25) |